These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22029386)

  • 41. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
    Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione.
    Żmudzki P; Chłoń-Rzepa G; Bojarski AJ; Zygmunt M; Kazek G; Mordyl B; Pawłowski M
    Arch Pharm (Weinheim); 2015 Apr; 348(4):229-41. PubMed ID: 25773578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
    Li AH; Moro S; Forsyth N; Melman N; Ji XD; Jacobson KA
    J Med Chem; 1999 Feb; 42(4):706-21. PubMed ID: 10052977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.
    Hendry N; Christie I; Rabiner EA; Laruelle M; Watson J
    Nucl Med Biol; 2011 Feb; 38(2):273-7. PubMed ID: 21315283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping of CBV changes in 5-HT(1A) terminal fields by functional MRI in the mouse brain.
    Mueggler T; Razoux F; Russig H; Buehler A; Franklin TB; Baltes C; Mansuy IM; Rudin M
    Eur Neuropsychopharmacol; 2011 Apr; 21(4):344-53. PubMed ID: 20656461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anxiolytic effects of prelimbic 5-HT(1A) receptor activation in the hemiparkinsonian rat.
    Hui YP; Wang T; Han LN; Li LB; Sun YN; Liu J; Qiao HF; Zhang QJ
    Behav Brain Res; 2015 Jan; 277():211-20. PubMed ID: 24906197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J; Kołaczkowski M; Bojarski AJ; Duszyńska B
    Eur J Med Chem; 2006 Jul; 41(7):874-81. PubMed ID: 16600439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT
    Franchini S; Manasieva LI; Sorbi C; Battisti UM; Fossa P; Cichero E; Denora N; Iacobazzi RM; Cilia A; Pirona L; Ronsisvalle S; Aricò G; Brasili L
    Eur J Med Chem; 2017 Jan; 125():435-452. PubMed ID: 27689727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a potent and selective 5-HT(1A) receptor agonist.
    Franchini S; Tait A; Prandi A; Sorbi C; Gallesi R; Buccioni M; Marucci G; De Stefani C; Cilia A; Brasili L
    ChemMedChem; 2009 Feb; 4(2):196-203. PubMed ID: 19101959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonin (5-HT) regulates neurite outgrowth through 5-HT1A and 5-HT7 receptors in cultured hippocampal neurons.
    Rojas PS; Neira D; Muñoz M; Lavandero S; Fiedler JL
    J Neurosci Res; 2014 Aug; 92(8):1000-9. PubMed ID: 24752854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
    McCreary AC; Glennon JC; Ashby CR; Meltzer HY; Li Z; Reinders JH; Hesselink MB; Long SK; Herremans AH; van Stuivenberg H; Feenstra RW; Kruse CG
    Neuropsychopharmacology; 2007 Jan; 32(1):78-94. PubMed ID: 16710314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization.
    Ramos AJ; Rubio MD; Defagot C; Hischberg L; Villar MJ; Brusco A
    Brain Res; 2004 Dec; 1030(2):201-20. PubMed ID: 15571670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.
    Russo O; Cachard-Chastel M; Rivière C; Giner M; Soulier JL; Berthouze M; Richard T; Monti JP; Sicsic S; Lezoualc'h F; Berque-Bestel I
    J Med Chem; 2009 Apr; 52(8):2214-25. PubMed ID: 19334715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Relevance for neuroplasticity and depression.
    Borroto-Escuela DO; Pérez-Alea M; Narvaez M; Tarakanov AO; Mudó G; Jiménez-Beristain A; Agnati LF; Ciruela F; Belluardo N; Fuxe K
    Biochem Biophys Res Commun; 2015 Jul; 463(3):180-6. PubMed ID: 25957476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of the 5-hydroxytryptamine (5-HT)1A receptor inverse agonists Rec 27/0224 and Rec 27/0074 on electrophysiological responses to 5-HT1A receptor activation in rat dorsal raphe nucleus and hippocampus in vitro.
    Corradetti R; Mlinar B; Falsini C; Pugliese AM; Cilia A; Destefani C; Testa R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):109-17. PubMed ID: 15951403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on 1-arylpiperazine derivatives with affinity for rat 5-HT7 and 5-HT1A receptors.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Perrone R; Tortorella V
    J Pharm Pharmacol; 2004 Feb; 56(2):247-55. PubMed ID: 15005884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neuroprotective effect of a new serotonin receptor agonist, BAY X3702, upon focal ischemic brain damage caused by acute subdural hematoma in the rat.
    Alessandri B; Tsuchida E; Bullock RM
    Brain Res; 1999 Oct; 845(2):232-5. PubMed ID: 10536203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons.
    Cowen DS; Johnson-Farley NN; Travkina T
    J Neurochem; 2005 May; 93(4):910-7. PubMed ID: 15857394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-HT1A receptor pharmacophores to screen for off-target activity of α1-adrenoceptor antagonists.
    Ngo T; Nicholas TJ; Chen J; Finch AM; Griffith R
    J Comput Aided Mol Des; 2013 Apr; 27(4):305-19. PubMed ID: 23625023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins.
    Byrtus H; Pawłowski M; Czopek A; Bojarski AJ; Duszyńska B; Nowak G; Kłodzińska A; Tatarczyńska E; Wesołowska A; Chojnacka-Wójcik E
    Eur J Med Chem; 2005 Aug; 40(8):820-9. PubMed ID: 16122584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.